Cargando…

Development of a neural network model to predict the presence of fentanyl in community drug samples

INTRODUCTION: Increasingly, Fourier-transform infrared (FTIR) spectroscopy is being used as a harm reduction tool to provide people who use drugs real-time information about the contents of their substances. However, FTIR spectroscopy has been shown to have a high detection limit for fentanyl and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ti, Lianping, Grant, Cameron J., Tobias, Samuel, Hore, Dennis K., Laing, Richard, Marshall, Brandon D. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343080/
https://www.ncbi.nlm.nih.gov/pubmed/37440523
http://dx.doi.org/10.1371/journal.pone.0288656
_version_ 1785072652885426176
author Ti, Lianping
Grant, Cameron J.
Tobias, Samuel
Hore, Dennis K.
Laing, Richard
Marshall, Brandon D. L.
author_facet Ti, Lianping
Grant, Cameron J.
Tobias, Samuel
Hore, Dennis K.
Laing, Richard
Marshall, Brandon D. L.
author_sort Ti, Lianping
collection PubMed
description INTRODUCTION: Increasingly, Fourier-transform infrared (FTIR) spectroscopy is being used as a harm reduction tool to provide people who use drugs real-time information about the contents of their substances. However, FTIR spectroscopy has been shown to have a high detection limit for fentanyl and interpretation of results by a technician can be subjective. This poses concern, given that some synthetic opioids can produce serious toxicity at sub-detectable levels. The objective of this study was to develop a neural network model to identify fentanyl and related analogues more accurately in drug samples compared to traditional analysis by technicians. METHODS: Data were drawn from samples analyzed point-of-care using combination FTIR spectroscopy and fentanyl immunoassay strips in British Columbia between August 2018 and January 2021. We developed neural network models to predict the presence of fentanyl based on FTIR data. The final model was validated against the results from immunoassay strips. Prediction performance was assessed using F1 score, accuracy, and area under the receiver-operating characteristic curve (AUROC), and was compared to results obtained from analysis by technicians. RESULTS: A total of 12,684 samples were included. The neural network model outperformed results from those analyzed by technicians, with an F1 score of 96.4% and an accuracy of 96.4%, compared to 78.4% and 82.4% with a technician, respectively. The AUROC of the model was 99.0%. Fentanyl positive samples correctly detected by the model but not by the technician were typically those with low fentanyl concentrations (median: 2.3% quantity by weight; quartile 1–3: 0.0%-4.6%). DISCUSSION: Neural network models can accurately predict the presence of fentanyl and related analogues using FTIR data, including samples with low fentanyl concentrations. Integrating this tool within drug checking services utilizing FTIR spectroscopy has the potential to improve decision making to reduce the risk of overdose and other negative health outcomes.
format Online
Article
Text
id pubmed-10343080
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-103430802023-07-14 Development of a neural network model to predict the presence of fentanyl in community drug samples Ti, Lianping Grant, Cameron J. Tobias, Samuel Hore, Dennis K. Laing, Richard Marshall, Brandon D. L. PLoS One Research Article INTRODUCTION: Increasingly, Fourier-transform infrared (FTIR) spectroscopy is being used as a harm reduction tool to provide people who use drugs real-time information about the contents of their substances. However, FTIR spectroscopy has been shown to have a high detection limit for fentanyl and interpretation of results by a technician can be subjective. This poses concern, given that some synthetic opioids can produce serious toxicity at sub-detectable levels. The objective of this study was to develop a neural network model to identify fentanyl and related analogues more accurately in drug samples compared to traditional analysis by technicians. METHODS: Data were drawn from samples analyzed point-of-care using combination FTIR spectroscopy and fentanyl immunoassay strips in British Columbia between August 2018 and January 2021. We developed neural network models to predict the presence of fentanyl based on FTIR data. The final model was validated against the results from immunoassay strips. Prediction performance was assessed using F1 score, accuracy, and area under the receiver-operating characteristic curve (AUROC), and was compared to results obtained from analysis by technicians. RESULTS: A total of 12,684 samples were included. The neural network model outperformed results from those analyzed by technicians, with an F1 score of 96.4% and an accuracy of 96.4%, compared to 78.4% and 82.4% with a technician, respectively. The AUROC of the model was 99.0%. Fentanyl positive samples correctly detected by the model but not by the technician were typically those with low fentanyl concentrations (median: 2.3% quantity by weight; quartile 1–3: 0.0%-4.6%). DISCUSSION: Neural network models can accurately predict the presence of fentanyl and related analogues using FTIR data, including samples with low fentanyl concentrations. Integrating this tool within drug checking services utilizing FTIR spectroscopy has the potential to improve decision making to reduce the risk of overdose and other negative health outcomes. Public Library of Science 2023-07-13 /pmc/articles/PMC10343080/ /pubmed/37440523 http://dx.doi.org/10.1371/journal.pone.0288656 Text en © 2023 Ti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ti, Lianping
Grant, Cameron J.
Tobias, Samuel
Hore, Dennis K.
Laing, Richard
Marshall, Brandon D. L.
Development of a neural network model to predict the presence of fentanyl in community drug samples
title Development of a neural network model to predict the presence of fentanyl in community drug samples
title_full Development of a neural network model to predict the presence of fentanyl in community drug samples
title_fullStr Development of a neural network model to predict the presence of fentanyl in community drug samples
title_full_unstemmed Development of a neural network model to predict the presence of fentanyl in community drug samples
title_short Development of a neural network model to predict the presence of fentanyl in community drug samples
title_sort development of a neural network model to predict the presence of fentanyl in community drug samples
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343080/
https://www.ncbi.nlm.nih.gov/pubmed/37440523
http://dx.doi.org/10.1371/journal.pone.0288656
work_keys_str_mv AT tilianping developmentofaneuralnetworkmodeltopredictthepresenceoffentanylincommunitydrugsamples
AT grantcameronj developmentofaneuralnetworkmodeltopredictthepresenceoffentanylincommunitydrugsamples
AT tobiassamuel developmentofaneuralnetworkmodeltopredictthepresenceoffentanylincommunitydrugsamples
AT horedennisk developmentofaneuralnetworkmodeltopredictthepresenceoffentanylincommunitydrugsamples
AT laingrichard developmentofaneuralnetworkmodeltopredictthepresenceoffentanylincommunitydrugsamples
AT marshallbrandondl developmentofaneuralnetworkmodeltopredictthepresenceoffentanylincommunitydrugsamples